iSpecimen, Inc. (ISPC)
0.817
-0.02
(-1.89%)
USD |
NASDAQ |
Oct 23, 16:00
0.806
-0.01
(-1.35%)
After-Hours: 20:00
iSpecimen Enterprise Value : -2.930M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | -2.930M |
| October 22, 2026 | -2.906M |
| October 21, 2026 | -2.815M |
| October 20, 2026 | -2.712M |
| October 19, 2026 | -2.788M |
| October 16, 2026 | -2.778M |
| October 15, 2026 | -2.605M |
| October 14, 2026 | -2.621M |
| October 13, 2026 | -2.529M |
| October 12, 2026 | -2.529M |
| October 09, 2026 | -2.453M |
| October 08, 2026 | -2.514M |
| October 07, 2026 | -2.499M |
| October 06, 2026 | -2.544M |
| October 05, 2026 | -2.575M |
| October 02, 2026 | -2.529M |
| October 01, 2026 | -2.438M |
| September 30, 2026 | -2.377M |
| September 29, 2026 | -2.301M |
| September 28, 2026 | -2.331M |
| September 25, 2026 | -2.255M |
| September 24, 2026 | -2.270M |
| September 23, 2026 | -2.331M |
| September 22, 2026 | -2.270M |
| September 21, 2026 | -2.164M |
| Date | Value |
|---|---|
| September 18, 2026 | -2.149M |
| September 17, 2026 | -2.118M |
| September 16, 2026 | -2.088M |
| September 15, 2026 | -2.149M |
| September 14, 2026 | -1.936M |
| September 11, 2026 | -1.936M |
| September 10, 2026 | -1.890M |
| September 09, 2026 | -1.814M |
| September 08, 2026 | -1.753M |
| September 04, 2026 | -1.829M |
| September 03, 2026 | -1.829M |
| September 02, 2026 | -1.905M |
| September 01, 2026 | -1.890M |
| August 31, 2026 | -1.829M |
| August 28, 2026 | -1.829M |
| August 27, 2026 | -1.738M |
| August 26, 2026 | -1.677M |
| August 25, 2026 | -1.738M |
| August 24, 2026 | -1.783M |
| August 21, 2026 | -1.601M |
| August 20, 2026 | -0.7177M |
| August 19, 2026 | -0.5502M |
| August 18, 2026 | -0.6111M |
| August 17, 2026 | -0.9003M |
| August 14, 2026 | -0.7481M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 8.893M |
| SCWorx Corp. | -1.068M |
| Health Catalyst, Inc. | 192.61M |
| GoodRx Holdings, Inc. | 1.447B |
| Claritev Corp. | 5.069B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.363M |
| Revenue (Quarterly) | 0.1519M |
| Total Expenses (Quarterly) | 1.515M |
| EPS Diluted (Quarterly) | -0.9773 |
| Gross Profit Margin (Quarterly) | -87.43% |
| Profit Margin (Quarterly) | -897.2% |
| Earnings Yield | -6.15K% |
| Normalized Earnings Yield | -6154.68 |